Something we concur on at last. GG has shown an aplomb in his understanding of the minutia of the US medical industry in the past, in M&A particularly.....
- Forums
- ASX - By Stock
- MSB
- Ann: Meeting Requested with FDA on Revascor Accelerated Approval
MSB
mesoblast limited
Add to My Watchlist
2.05%
!
$1.79

Ann: Meeting Requested with FDA on Revascor Accelerated Approval, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.79 |
Change
-0.038(2.05%) |
Mkt cap ! $2.261B |
Open | High | Low | Value | Volume |
$1.80 | $1.83 | $1.76 | $9.215M | 5.169M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 22308 | $1.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.79 | 37335 | 26 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 21415 | 1.785 |
21 | 172436 | 1.780 |
15 | 34368 | 1.775 |
11 | 55708 | 1.770 |
10 | 61246 | 1.765 |
Price($) | Vol. | No. |
---|---|---|
1.790 | 34149 | 22 |
1.795 | 31228 | 7 |
1.800 | 97014 | 11 |
1.805 | 81685 | 7 |
1.810 | 53818 | 5 |
Last trade - 14.43pm 18/06/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online